Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice
Ying-Hua Wang, Betty Diamond
Ying-Hua Wang, Betty Diamond
Published July 17, 2008
Citation Information: J Clin Invest. 2008;118(8):2896-2907. https://doi.org/10.1172/JCI35618.
View: Text | PDF
Research Article Immunology

B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice

  • Text
  • PDF
Abstract

Autoreactive B cells are regulated in the BM during development through mechanisms, including editing of the B cell receptor (BCR), clonal deletion, and anergy. Peripheral B cell tolerance is also important for protection from autoimmune damage, although the mechanisms are less well defined. Here we demonstrated, using a mouse model of SLE-like serology, that during an autoimmune response, RAG was reinduced in antigen-activated early memory or preplasma B cells. Expression of RAG was specific to antigen-reactive B cells, required the function of the IL-7 receptor (IL-7R), and contributed to maintenance of humoral tolerance. We also showed that soluble antigen could diminish a non-autoreactive antibody response through induction of BCR revision. These data suggest that tolerance induction operates in B cells at a postactivation checkpoint and that BCR revision helps regulate autoreactivity generated during an ongoing immune response.

Authors

Ying-Hua Wang, Betty Diamond

×

Figure 6

Soluble antigen induces RAG and receptor revision in the spleen of immunized mice.

Options: View larger image (or click on image) Download as PowerPoint
Soluble antigen induces RAG and receptor revision in the spleen of immun...
(A) Expression of RAG in DWEYS tetramer-binding cells requires the presence of circulating dsDNA in the plasma. BALB/c naive splenocytes were adoptively transferred to Rag2–/– mice. Three weeks later, the recipient mice were immunized with DWEYS-MAP as described in Figure 3. From day 9 through day 15 following immunization, 500 μg active or heat-inactivated bovine DNase I were administered to the mice. Tetramer-reactive cells were sorted on day 16, and Rag1 and Rag2 were analyzed by qPCR. (B) Soluble 10-2–BSA induces RAG in the spleen of mice immunized with 10-2–KLH. (C and D) Receptor revision is induced in antigen-reactive B cells by soluble 10-2–BSA. BALB/c mice were immunized with 10-2–KLH in CFA on day 0 and boosted with 10-2–KLH in incomplete Freund adjuvant on day 7. On days 13, 14, and 15, 1 mg of 10-2–BSA or BSA were administered. qPCR analysis for the mRNA of l chain (Igl-V1) was done on 10-2–tetramer reactive cells, and nonreactive naive B cells were sorted on day 16 (C). Data (mean ± SEM) are representative of 2 independent experiments. Serum levels of Igλ were measured by ELISA (D). Five mice were included in each group. The experiment was repeated twice. **P < 0.01, 2-tailed Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts